Medtronic and the FDA were both aware of battery and wire connection defects in a now-recalled heart failure pacemaker for over a year before patients developed serious side effects, according to a report published in JAMA Internal Medicine.
When the FDA did issue a recall, the report found, the agency’s information was incomplete and underestimated the severity of the pacemaker’s defects.
